Skip to content
Preprint · CC-BY via OpenAlex

Therapeutic potential of boosting NAD+ levels in aging and age-related bone loss

Yogita Sonar

Queensland University of Technology · 2023

Abstract

This thesis presents a study exploring the use of Nicotinamide Mononucleotide (NMN) to boost Nicotinamide Adenine Dinucleotide (NAD) levels and its potential in combating aging and age-related bone loss. NAD, a vital cellular coenzyme, regulates DNA repair and energy production. As NAD declines with age, it contributes to various age-related health problems. In a four-week animal model study, we investigated NMN supplementation's ability to raise NAD levels and its implications for countering age-related bone loss. Our results offer promising insights into the therapeutic potential of NMN for addressing NAD-related aging issues.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5204/thesis.eprints.243826
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
Sonar, Y. (2023). Therapeutic potential of boosting NAD+ levels in aging and age-related bone loss. <em>Queensland University of Technology</em>. https://doi.org/10.5204/thesis.eprints.243826
Vancouver
Sonar Y. Therapeutic potential of boosting NAD+ levels in aging and age-related bone loss. Queensland University of Technology. 2023. doi:10.5204/thesis.eprints.243826.
BibTeX
@unpublished{yogita2023Therap, title = {Therapeutic potential of boosting NAD+ levels in aging and age-related bone loss}, author = {Yogita Sonar}, journal = {Queensland University of Technology}, year = {2023}, doi = {10.5204/thesis.eprints.243826}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings